Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide
BackgroundApalutamide, an androgen receptor inhibitor, has shown good efficacy in treating prostate cancer (PCa). However, dermatological adverse events (dAEs) are common and threatening, and relevant studies in China are limited.MethodsThis was a retrospective, single-center analysis. We included P...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1530919/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|